Cultural and economic shifts are shaping the probiotics market, fostering dietary supplement and food and beverage industries. Consumer trends allude to the rising prominence of probiotics, which offer a slew of health upsides, including digestive and immune health and advancements in weight management. Brands are zeroing in on additional probiotic health benefits to keep up with the soaring consumer demand. A few studies have claimed that certain strains of probiotic bacteria might prevent the common cold and influenza and/or reduce the duration of the disease. The strong link of probiotics with gut health and immunity has steered a wave of trends in digestive health.
Notably, products with probiotics claims, such as frozen
yogurt, fermented drinks, cereals, snack bars, infant formula and dairy-based
ice creams, have gained ground. In January 2024, the International Food
Information Council (IFIC) inferred that a Consumer Insights on Gut Health and
Probiotics Survey—conducted by IFIC—found that one in four Americans (those who
try to consume probiotics) stated they commonly seek them in wellness drinks.
Surging demand for microbiome-nurturing ingredients has
prompted manufacturers and other leaders to emphasize women’s health and
cognitive health. Prevailing trends indicate the global probiotics market could
reach USD 220.14 billion in revenue in 2030. The growth trajectory is a major
indicator for stakeholders as to where the industry is heading.
Probiotics Market Report Highlights
- The
demand for probiotic dietary supplements is expected to grow at a CAGR of
14.1% from 2023 to 2030, driven by the growing consumer awareness of the
health benefits offered by probiotic supplements
- The
demand for yeast-based probiotics is projected to grow at a CAGR of 13.4%
during the forecast period. Dietary supplements are made using yeast as it
has proteins, amino acids, vitamin B, and peptides, and is safe for
all age groups
- The
sales of probiotics through supermarkets/hypermarkets dominated the market
in 2022 with a revenue share of over 30% and are expected to continue
dominance throughout the forecast period. The availability of a wide range
of product offerings, also enabling easy comparisons for customers, is
expected to drive this dominance
- The
demand for probiotics in the Middle East & Africa region is expected
to grow at a CAGR of nearly 15% during the forecast period. It is mainly
driven by the increasing demand in countries, such as Saudi Arabia, South
Africa, and UAE
Recent Development
·
In June 2023, ADM announced the
opening of a USD 30 million state-of-the-art manufacturing facility in Spain to
cater to the unmet demand for probiotics and postbiotics.
·
In April 2023, the FDA approved Seres Therapeutics’ live oral
microbiome capsule Vowst and will be commercialized by Nestle using its
gastroenterology sales force.
·
In November 2022, Nestlé made a
breakthrough discovery and product in infant microbiome, launched under the
brand name WYETH S-26® ULTIMA®, in collaboration with Pennington Biomedical
Research Center and Rhode Island Hospital, USA.
·
In April 2022, Symrise and Probi collaboratively introduced
SymFerment®, a sustainable probiotic skincare ingredient.
·
In August 2021, Chr. Hansen Holding A/S introduced its new
science-based stable live probiotics product portfolio for the pet segment. The
line-up included CHR. HANSEN PET-PROSTART™ for kittens and puppies, CHR. HANSEN
PET-PROESSENTIALS™ for adult pets, and CHR. HANSEN PET-PROVITAL™ for senior
cats and dogs.
·
In July 2021, Symrise launched its
first processed probiotic dedicated to oral care called SymReboot™ OC which
promotes a healthy oral microbiome and strengthens gums.
·
In May 2021, Chr. Hansen Holding A/S launched Bovacillus™, an
innovative product to support beef cattle health and dairy farming.
Explore
Horizon, the world's most expansive market research database
